Bio-Techne
TECH
#1989
Rank
A$14.54 B
Marketcap
A$93.36
Share price
-2.93%
Change (1 day)
-18.15%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.59 Billion

According to Bio-Techne's latest financial reports the company's total debt is A$0.59 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30A$0.62 B-7.92%
2023-06-30A$0.68 B44.46%
2022-06-30A$0.47 B-15.75%
2021-06-30A$0.56 B-10.7%
2020-06-30A$0.62 B-12.67%
2019-06-30A$0.71 B57.07%
2018-06-30A$0.45 B2.27%
2017-06-30A$0.44 B250.12%
2016-06-30A$0.12 B27.75%
2015-06-30A$0.10 B629.16%
2014-06-30A$13.72 M
2006-06-30A$18.15 M-5.23%
2005-06-30A$19.15 M-16.57%
2004-06-30A$22.95 M-10.26%
2003-06-30A$25.58 M-20.44%
2002-06-30A$32.15 M-13.09%
2001-06-30A$37 M12.54%
2000-06-30A$32.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
A$54.00 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$2.11 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$29.27 B 4,803.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$25.51 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$3.21 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
A$31.54 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$4.54 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA